Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

NCT04798781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Hepatocellular Carcinoma

Interventions

DRUG: Telatinib
DRUG: Keytruda

Sponsor

Andrew Hendifar, MD

Collaborators

[object Object]